Suppr超能文献

miR-146b-5p通过靶向结直肠癌中的PDHB来调节细胞生长、侵袭和代谢。

miR-146b-5p regulates cell growth, invasion, and metabolism by targeting PDHB in colorectal cancer.

作者信息

Zhu Yuanzeng, Wu Gang, Yan Wenfeng, Zhan Han, Sun Peichun

机构信息

The First Department of Gastrointestinal Surgery, Henan Province People's HospitalZhengzhou 450003, Henan, China.

出版信息

Am J Cancer Res. 2017 May 1;7(5):1136-1150. eCollection 2017.

Abstract

MiRNA have been found to play a role in a plethora of cellular processes of cancer cells such as cell apoptosis, cell proliferation, invasion, migration metabolism and stem cell differentiation. Dysregulation of miR-146b-5p has been documented in a variety of human malignancies. However, the biological functions and molecular mechanisms of miR-146b-5p in ovarian cancer remain unknown. In this study, our results show that miR-146b-5p was unregulated in colorectal cancer (CRC) tissues compared with the adjacent non-cancerous tissues. Ectopic overexpression of miR-146b-5p in CRC promoted cell growth, invasion and glycolysis, while knockdown of miR-146b-5p inhibited the growth, invasion and glycolysis of CRC cells. The oncogenic effect of miR-146b-5p is also confirmed in vivo. Mechanically, miR-146b-5p targets the 3'-UTR of pyruvate dehydrogenase B (PDHB) and exerts oncogenic effect. Overexpression of PDHB abolished the oncogenic effects of miR-146b-5p on the growth, invasion and glycolysis of CRC cells. Taken together, our results show that miR-146b-5p is an oncogenic miRNA in CRC which exerts its effect by directly targeting PDHB.

摘要

已发现微小RNA(miRNA)在癌细胞的众多细胞过程中发挥作用,如细胞凋亡、细胞增殖、侵袭、迁移、代谢和干细胞分化。miR-146b-5p的失调在多种人类恶性肿瘤中已有记载。然而,miR-146b-5p在卵巢癌中的生物学功能和分子机制仍不清楚。在本研究中,我们的结果表明,与相邻的非癌组织相比,miR-146b-5p在结直肠癌(CRC)组织中表达上调。在CRC中异位过表达miR-146b-5p可促进细胞生长、侵袭和糖酵解,而敲低miR-146b-5p则抑制CRC细胞的生长、侵袭和糖酵解。miR-146b-5p的致癌作用在体内也得到证实。从机制上讲,miR-146b-5p靶向丙酮酸脱氢酶B(PDHB)的3'-UTR并发挥致癌作用。PDHB的过表达消除了miR-146b-5p对CRC细胞生长、侵袭和糖酵解的致癌作用。综上所述,我们的结果表明,miR-146b-5p是CRC中的一种致癌miRNA,它通过直接靶向PDHB发挥作用。

相似文献

2
miR-146b-5p promotes colorectal cancer progression by targeting TRAF6.
Exp Ther Med. 2022 Mar;23(3):231. doi: 10.3892/etm.2022.11155. Epub 2022 Jan 20.
3
5
MiR-203 promotes the growth and migration of ovarian cancer cells by enhancing glycolytic pathway.
Tumour Biol. 2016 Nov;37(11):14989-14997. doi: 10.1007/s13277-016-5415-1. Epub 2016 Sep 21.
7
MicroRNA-146b-5p as an oncomiR promotes papillary thyroid carcinoma development by targeting CCDC6.
Cancer Lett. 2019 Feb 28;443:145-156. doi: 10.1016/j.canlet.2018.11.026. Epub 2018 Nov 29.
8
miR-142-5p promotes development of colorectal cancer through targeting SDHB and facilitating generation of aerobic glycolysis.
Biomed Pharmacother. 2017 Aug;92:1119-1127. doi: 10.1016/j.biopha.2017.05.134. Epub 2017 Jun 12.
9
MiR-146b-5p functions as a suppressor miRNA and prognosis predictor in non-small cell lung cancer.
J Cancer. 2017 Jun 30;8(9):1704-1716. doi: 10.7150/jca.16961. eCollection 2017.

引用本文的文献

1
Epigenetics and Herbs: Potential Therapeutic Strategies for Osteoarthritis of the Knee.
J Pain Res. 2025 Jun 26;18:3217-3261. doi: 10.2147/JPR.S517224. eCollection 2025.
2
MiR-146b overexpression promotes bladder cancer cell growth via the SMAD4/C-MYC/Cyclin D1 axis.
Front Oncol. 2025 Mar 28;15:1565638. doi: 10.3389/fonc.2025.1565638. eCollection 2025.
3
inhibits glycolysis and promotes apoptosis of colorectal cancer cells via β‑catenin signaling.
Oncol Lett. 2025 Jan 7;29(3):126. doi: 10.3892/ol.2025.14873. eCollection 2025 Mar.
4
Identification of cuproptosis-related genes in Alzheimer's disease based on bioinformatic analysis.
Eur J Med Res. 2024 Oct 12;29(1):495. doi: 10.1186/s40001-024-02093-y.
5
A cuproptosis-based prognostic model for predicting survival in low-grade glioma.
Aging (Albany NY). 2024 May 9;16(10):8697-8716. doi: 10.18632/aging.205834.
6
Analysis of the potential biological value of pyruvate dehydrogenase E1 subunit β in human cancer.
World J Gastrointest Oncol. 2024 Jan 15;16(1):144-181. doi: 10.4251/wjgo.v16.i1.144.
7
Anticancer effect of hUC-MSC-derived exosome-mediated delivery of PMO-miR-146b-5p in colorectal cancer.
Drug Deliv Transl Res. 2024 May;14(5):1352-1369. doi: 10.1007/s13346-023-01469-7. Epub 2023 Nov 17.
8
Progress in the research of cuproptosis and possible targets for cancer therapy.
World J Clin Oncol. 2023 Sep 24;14(9):324-334. doi: 10.5306/wjco.v14.i9.324.
10
Identification of cuproptosis-related molecular subtypes and a novel predictive model of COVID-19 based on machine learning.
Front Immunol. 2023 Jul 17;14:1152223. doi: 10.3389/fimmu.2023.1152223. eCollection 2023.

本文引用的文献

1
MiR-203 promotes the growth and migration of ovarian cancer cells by enhancing glycolytic pathway.
Tumour Biol. 2016 Nov;37(11):14989-14997. doi: 10.1007/s13277-016-5415-1. Epub 2016 Sep 21.
4
MicroRNAs in colorectal carcinoma--from pathogenesis to therapy.
J Exp Clin Cancer Res. 2016 Mar 10;35:43. doi: 10.1186/s13046-016-0320-4.
5
Pyruvate dehydrogenase B promoted the growth and migration of the nasopharyngeal carcinoma cells.
Tumour Biol. 2016 Aug;37(8):10563-9. doi: 10.1007/s13277-016-4922-4. Epub 2016 Feb 8.
10
NOS Inhibition Modulates Immune Polarization and Improves Radiation-Induced Tumor Growth Delay.
Cancer Res. 2015 Jul 15;75(14):2788-99. doi: 10.1158/0008-5472.CAN-14-3011. Epub 2015 May 19.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验